4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-17-011195
Director acquired 16,892 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Slager David Mark Director | 2017-10-31 | Option exercise | +16,892 | $3.77 | $63,609 | 1,316,328 | I |
| Derivatives | |||||||
| Slager David Mark Director | 2017-10-31 | Option exercise · Warrant (right to buy) | −16,892 | $1.18 | $19,926 | 0 | I |
Loading xslF345X03/f4103117slager_oramedpharm.xml…